Oxybuprocaine
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Surface anesthesia of the conjunctiva and cornea after the application of eye drops occurs after 30 seconds and lasts for 15 minutes.
Indications
Local anesthesia in ophthalmology:
- Measurement of intraocular pressure (tonometry).
- Gonioscopy.
- Diagnostic scraping conjunctiva.
- Removing foreign bodies and stitches from the cornea and conjunctiva.
- Short-term surgery on the cornea and conjunctiva.
Composition
In 1 ml of eye drops 0.4% is contained.
Active substance: aboutXibuprocaine (in the form of hydrochloride) 4 mg.
Excipients: benzalkonium chloride, boric acid, sodium chloride, disodium edetate, water d / i.
No customer reviews for the moment.
Dosage and Administration
The drug is instilled into the conjunctival sac 1 drop.
Long-term anesthesia (up to 1 h) provides 3-time instillation with an interval of 4-5 minutes.
Adverse reactions
maybe
Short-term tingling sensation, burning and redness of the conjunctiva, allergic reactions.
Seldom
Keratitis
Contraindications
Individual hypersensitivity to the drug.
Drug interactions
Negative or positive effects are not described in the literature with simultaneous administration of oxybuprocaine and other eye drops traditionally used in the conjunctival sac.
It is noted that oxybuprocaine can theoretically reduce the antibacterial activity of sulfonamides.
Pregnancy and Lactation
Clinical experience in the use of the drug during pregnancy and lactation is not enough. The use of Inokain during pregnancy and during breastfeeding is possible only in cases where the expected benefit of therapy for the mother outweighs the potential risk to the fetus or infant.
Special instructions
The drug is intended only for instillation in the conjunctival sac. Do not use for injection.
Not intended for long-term therapy in the complex treatment of eye diseases.
Prolonged, repeated and prolonged use (as well as other local anesthetics) can lead to persistent corneal opacities.
During anesthesia, it is necessary to protect the eye from irritating chemical effects, foreign bodies and friction.
Use in Pediatrics
There is not enough experience in the use of the drug in children. Application of Inokain in children is possible only in cases when the expected benefit of therapy exceeds the risk of possible side effects.
- Active ingredient: Oxybuprocaine
- The original domestic drug oxolin: Refined structure of the drug and summarized experience of oxolin ointment use in medicine
- Periorbital allergic contact dermatitis from oxybuprocaine
- Diclofenac vs oxybuprocaine eyedrops for analgesia in paediatric strabismus surgery
- The influence of oxybuprocaine (Novesine) on the intraocular pressure
- Haemodynamic stability during general anaesthesia for intra-ocular surgery: the effect of topical oxybuprocaine
- Bradycardia as a side-effect to oxybuprocaine
- Intrathecal oxybuprocaine and proxymetacaine produced potent and long-lasting spinal anesthesia in rats
- Clonidine as adjuvant for oxybuprocaine, bupivacaine or dextrorphan has a significant peripheral action in intensifying and prolonging analgesia in response to local dorsal cutaneous noxious pinprick in rats
- Oxybuprocaine induces a false positive
- Oxybuprocaine induces a false-positive response in immunochromatographic SAS Adeno Test
- Oxybuprocaine
- Changes in central corneal thickness values after instillation of oxybuprocaine hydrochloride 0.4%
- Cyclopentolate/oxybuprocaine
- Oxybuprocaine
- Oxybuprocaine abuse
- Oxybuprocaine abuse
- Oxybuprocaine
- Oxybuprocaine
- Oxybuprocaine
- Oxybuprocaine
- Comparison of the Influence of Nonpreserved Oxybuprocaine and a Preserved Artificial Tear (Thera Tears) on Human Corneal Thickness Measured by Two Pachymeters
- New Ion-Selective Electrodes for Determination of Bupivacaine and Oxybuprocaine